Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular pathways in low grade B-cell lymphoma

G Gaidano1, C Pastore, D Capello

  • 1Dipartimento di Scienze Biomediche e Oncologia Umana, Ospedale San Luigi, Università di Torino, Orbassano-Torino, Italy.

Leukemia & Lymphoma
|May 7, 1998
PubMed
Summary

Low-grade B-cell non-Hodgkin's lymphomas (B-NHL) exhibit diverse genetic pathways. Identifying these distinct genetic categories aids in therapeutic stratification and monitoring minimal residual disease in B-NHL patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Life Cycle Assessment of a system for the extraction and transformation of Waste Water Treatment Sludge (WWTS)-derived lipids into biodiesel.

The Science of the total environment·2023
Same author

Foliar application of specific yeast derivative enhances anthocyanins accumulation and gene expression in Sangiovese cv (Vitis vinifera L.).

Scientific reports·2020
Same author

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.

Blood cancer journal·2018
Same author

Characterization of Monilinia spp. Populations on Stone Fruit in South Italy.

Plant disease·2018
Same author

Comparison of different types of landfill leachate treatments by employment of nontarget screening to identify residual refractory organics and principal component analysis.

The Science of the total environment·2018

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Low-grade B-cell non-Hodgkin's lymphomas (B-NHL) are a heterogeneous group of disorders.
  • These include B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CCL/SLL), lymphoplasmacytoid lymphoma (LPL), follicular lymphoma (FL), mucosa-associated lymphoid tissue lymphoma (MALTL), and splenic lymphoma with villous lymphocytes (SLVL).

Purpose of the Study:

  • To elucidate the distinct molecular pathogenesis and genetic pathways associated with each clinicopathologic category of low-grade B-NHL.
  • To explore the potential of these genetic lesions for therapeutic stratification and minimal residual disease monitoring.

Main Methods:

  • Review and synthesis of existing literature on the molecular genetics of low-grade B-NHL subtypes.
  • Analysis of specific genetic alterations, including chromosomal abnormalities and gene mutations, associated with each lymphoma type.

Related Experiment Videos

Main Results:

  • B-CCL/SLL frequently shows 13q14 deletions and trisomy 12; Richter's syndrome associates with p53 disruption.
  • LPL is characterized by t(9;14)(p13;q32) leading to PAX-5 deregulation in 40-50% of cases.
  • FL consistently harbors BCL-2 rearrangements, with some cases accumulating p53 mutations and evolving to high-grade B-NHL.
  • Low-grade MALTL often presents trisomy 3 and occasional p53 mutations; SLVL has a fraction of cases with p53 mutations.

Conclusions:

  • Distinct genetic pathways characterize different low-grade B-NHL subtypes.
  • Identification of these genetic categories is crucial for effective therapeutic stratification.
  • Genetic lesions serve as valuable molecular markers for monitoring minimal residual disease in low-grade B-NHL.